22nd Century Group, Inc. is a leading agricultural biotechnology company, with a focus on enhancing health and wellness through plant science. Established in 1998, the company has a strong presence in the Biotechnology and Health Care industries. 22nd Century Group is dedicated to advancing human health through its expertise in reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology. Notably, GVB Biopharma has recently become a part of the 22nd Century Group.
The company's most recent investment was in Post-IPO Equity, signifying a forward-looking strategy. At 17 October 2023, the company attracted this investment, marking a significant event in its history. The details of the last investment investors are yet to be announced, signifying an upcoming phase of growth and potential partnerships.